Literature DB >> 2555003

Analytic results for quantifying HIV infectivity.

J L Spouge, S P Layne, M Dembo.   

Abstract

In a separate paper, we developed a mathematical model describing HIV infection and used it to suggest experiments for quantifying characteristic viral parameters. In this paper we generalize the model to any well-mixed assay system. We also present complete and rigorous derivations of fundamental results needed for the design and analysis of HIV infectivity assays. The model is applicable to infectious agents with multiple receptors for their target cell (e.g. HIV, Epstein-Barr virus and Plasmodium), and to blockers (both reversible and irreversible), as long as blocker and target cells are the same diffusion compartment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555003     DOI: 10.1007/BF02459657

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  11 in total

1.  HIV infection is blocked in vitro by recombinant soluble CD4.

Authors:  R A Fisher; J M Bertonis; W Meier; V A Johnson; D S Costopoulos; T Liu; R Tizard; B D Walker; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

2.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

Authors:  A Traunecker; W Lüke; K Karjalainen
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.

Authors:  R E Hussey; N E Richardson; M Kowalski; N R Brown; H C Chang; R F Siliciano; T Dorfman; B Walker; J Sodroski; E L Reinherz
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

4.  Fluctuation-dominated kinetics in diffusion-controlled reactions.

Authors: 
Journal:  Phys Rev A Gen Phys       Date:  1985-07

5.  Receptor molecule blocks HIV.

Authors:  R A Weiss
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

Review 6.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

7.  Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

Authors:  M Kowalski; J Potz; L Basiripour; T Dorfman; W C Goh; E Terwilliger; A Dayton; C Rosen; W Haseltine; J Sodroski
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

8.  Quantifying the infectivity of human immunodeficiency virus.

Authors:  S P Layne; J L Spouge; M Dembo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic mice.

Authors:  P L Nara; N M Dunlop; W G Robey; R Callahan; P J Fischinger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

10.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.

Authors:  D H Smith; R A Byrn; S A Marsters; T Gregory; J E Groopman; D J Capon
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

View more
  3 in total

1.  Blocking of human immunodeficiency virus infection depends on cell density and viral stock age.

Authors:  S P Layne; M J Merges; J L Spouge; M Dembo; P L Nara
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 2.  Molecular determinants of the ratio of inert to infectious virus particles.

Authors:  P J Klasse
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

3.  Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks.

Authors:  Star M Dunham-Ems; Melissa J Caimano; Utpal Pal; Charles W Wolgemuth; Christian H Eggers; Anamaria Balic; Justin D Radolf
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.